Preferred Label : Waardenburg syndrome, type 2e;
Symbol : WS2E;
CISMeF acronym : WS2E;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Waardenburg syndrome, type iie; Waardenburg syndrome, type 2e, with or without neurologic involvement; Ws2e, with or without neurologic involvement; Hypogonadotropic hypogonadism with anosmia and deafness, with or without hypopigmentation;
Description : Waardenburg syndrome type 2 is an auditory-pigmentary syndrome characterized by pigmentary
abnormalities of the hair, skin, and eyes; congenital sensorineural hearing loss;
and the absence of 'dystopia canthorum,' the lateral displacement of the inner canthus
of each eye, which is seen in some other forms of WS (review by Read and Newton, 1997).
Individuals with WS type 2E, which is caused by mutation in the SOX10 gene (602229),
may have neurologic abnormalities, including mental impairment, myelination defects,
and ataxia. Waardenburg syndrome type 2 is genetically heterogeneous (see WS2A; 193510).
For a description of other clinical variants of Waardenburg syndrome, see WS1 (193500),
WS3 (148820), and WS4 (277580).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the SRY-box-10 gene (SOX10, 602229.0005);
Prefixed ID : #611584;
Origin ID : 611584;
UMLS CUI : C2700405;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)